Efficacy, safety, and impact of fluorescein in frameless stereotactic needle biopsies – a case series
Neurosurgical Review · 2024
DOI: 10.1007/s10143-024-02758-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosurgical Review, 2024. Verfasst von Marcos Dellaretti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Santa Casa de BH e Faculdade Santa Casa BH, Belo Horizonte, MG, Brasil. mdellaretti@mac.com. Hauptthemen laut MEDLINE: Fluorescein, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Stereotactic needle biopsy stands as a crucial method for diagnosing intracranial lesions unsuitable for surgical intervention. Nonetheless, the potential for sampling errors lead to innovative approaches to enhance diagnostic precision. This study contrasts the outcomes of patients undergoing fluorescein-assisted frameless stereotactic needle biopsy with those receiving traditional biopsies to evaluate the impact on diagnostic accuracy and safety. This study included patients with contrast-enhancing intracranial lesions, comprising a prospective group undergoing fluorescein-assisted biopsies and a retrospective group undergoing conventional biopsies at the same institution. We've collected data on demographics, procedural specifics, diagnostic outcomes, and postoperative events. A comparative analysis involved 43 patients who received fluorescein-assisted biopsies against 77 patients who underwent conventional biopsies. The average age was 60.5 years. The fluorescein group exhibited a 93% success rate in diagnosis, markedly higher than the 70.1% in the non-fluorescein group (OR = 5.67; 95%IC: 1.59-20.24; p < 0.01). The rate of complications was statistically similar across both cohorts. Despite its established value, stereotactic needle biopsy is susceptible to inaccuracies and complications. The application of fluorescence-based adjuncts like 5-ALA and fluorescein has been investigated to improve diagnostic fidelity and reduce risks. These technologies potentially minimize the necessity for multiple biopsies, decrease surgical duration, and provide immediate verification of tumor presence. Fluorescein-assisted stereotactic biopsy emerges as an effective, secure alternative to conventional methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Santa Casa de BH e Faculdade Santa Casa BH, Belo Horizonte, MG, Brasil. mdellaretti@mac.com.
- Santa Casa de BH e Faculdade Santa Casa BH, Belo Horizonte, MG, Brasil.
- Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brasil.
Zitieren
APA
Dellaretti, M., de Lima, F. B. F., de Sena, P. H. V. P., Figueiredo, H. P. G., Albuquerque, J. P. S., Gomes, F. C., Dias Faria, B. C., & de Almeida, J. C. (2024). Efficacy, safety, and impact of fluorescein in frameless stereotactic needle biopsies – a case series. Neurosurgical Review. https://doi.org/10.1007/s10143-024-02758-6
Vancouver
Dellaretti M, de Lima FBF, de Sena PHVP, Figueiredo HPG, Albuquerque JPS, Gomes FC, et al. Efficacy, safety, and impact of fluorescein in frameless stereotactic needle biopsies – a case series. Neurosurgical Review. 2024. doi:10.1007/s10143-024-02758-6
BibTeX
@article{Dellaretti2024,
author = {Dellaretti, Marcos and de Lima, Franklin Bernardes Faraj and de Sena, Pedro Henrique Velasco Pondé and Figueiredo, Hian Penna Gavazza and Albuquerque, João Pedro Santos and Gomes, Fernando Cotrim and Dias Faria, Barbara Caroline and de Almeida, Júlio César},
title = {Efficacy, safety, and impact of fluorescein in frameless stereotactic needle biopsies – a case series},
journal = {Neurosurgical Review},
year = {2024},
doi = {10.1007/s10143-024-02758-6}
}
EUVIMED